Bob Apple is President/CEO at Antares Pharma Inc. See Bob Apple's compensation, career history, education, & memberships. — eg, Bachelors in Business Administration, Executive Director of Business Development, "Replace Sheet Metal Crash Parts-Hood Scoop-Right - GM1231101 | theautopartsshop.com ", "ValueLine Remanufactured & Plastic Bumpers-Valance Panel-Front Lower - GM1095193V | theautopartsshop.com ", 23e2 Digital Marketing - PPC | Web Design | SEO Toronto. Jack HowarthVice President, Corporate Affairs609-359-3016jhowarth@antarespharma.com. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1 … Of this total $572,000 was received as a salary, $427,124 was received as a bonus, $850,300 was received in stock options, $1,651,248 was awarded as stock and $14,283 came from other types of compensation. Prior to Egalet, he served as Chief Commercial Officer at Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company. Robert Apple joined Antares Pharma in 2006. Bob Apple has been the CEO of Antares Pharma, Inc. (NASDAQ:ATRS) since 2016. Company is incorporated on7th December 2015. The Compa The current status of the business is Active. Forward-looking statements are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Robert Apple – CEO, President & Director. Can’t find the 483 you’re looking for? and Leonard S. Jacob's (collectively, "Individual Defendants") and Antares Pharma, Inc:s ("Antares" or the "Company") Motion to Dismiss pursuant to Federal Rules of Civil Founded. EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple… $0.0800. Fickenscher, 100 Princeton South, Suite 300, Ewing, NJ, 08628, USA The … Mr. Shea will be responsible for leading all commercial activities including sales, sales operations, marketing, trade and market access for the Company and will report to Robert F. Apple, Antares Pharma’s President and Chief Executive Officer. Antares Pharma, Inc. (Antares) ist ein spezialisiertes Pharmaunternehmen, das sich auf die Entwicklung und Vermarktung von selbst verwalteten parenteralen Arzneimitteln und Technologien konzentriert. View Robert Apple's business profile as President & Chief Executive Officer at Antares Pharma. Market Cap. Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple has been promoted to Chief Operating Officer effective immediately. Robert F. Apple, President and Chief Executive Officer of Antares Pharma, stated, “We are very pleased to have someone with Pat’s extensive sales and marketing background join the Antares senior leadership team. Mr. Shea has over three decades of sales, marketing, market access and commercial operations experience. Antares Pharma, Inc. is a Washington Foreign Profit Corporation filed on September 15, 2016. See the full leadership team at Craft. Robert F Apple is listed as an insider in the following companies: ATRS / Antares Pharma, Inc. Robert F. Apple, President and Chief Executive Officer of Antares Pharma, stated, “We are very pleased to have someone with Pat’s extensive sales and marketing background join the Antares … New Jersey’s Antares Pharma snared the license to Ferring Pharmaceuticals' nocturia drug Nocdurna—the first and only ... president and CEO of the company Robert Apple said. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various stages of development, as well as significant strategic alliances with industry leading pharmaceutical companies including Teva Pharmaceutical Industries, Ltd. (Teva), AMAG Pharmaceuticals, Inc. (AMAG), Pfizer Inc. (Pfizer) and Idorsia Pharmaceuticals Ltd. (Idorsia). Company Profile. ANTARES PHARMA, INC. From Ewing Reviews. View Robert Apple's business profile as President & Chief Executive Officer at Antares Pharma. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1 … EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. Find contact's direct phone number, email address, work history, and more. ATRS. Our … Antares Pharma story: Acquisition by Robert Apple of tradable shares of Domtar subject to Rule 16b 3 and other headlines for Antares Pharma Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. 10 Nov 2020 Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference Read More. Antares Pharma's President and Chief Executive Officer is Robert F. Apple. Antares Pharma, Inc. Common Stock, also called Antares Pharma, is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Additional information concerning these and other factors that may cause actual results to differ materially from those anticipated in the forward-looking statements is contained in the "Risk Factors" section of the Company's Annual Report on Form 10-K, and in the Company's other periodic reports and filings with the Securities and Exchange Commission. Portal des FreeMail-Pioniers mit Nachrichten und vielen Services. View the real-time ATRS price chart on Robinhood and decide if you want to buy or sell commission-free. Employees. Before that he served as senior vice president of sales and marketing for the U.S. pharmaceutical operations at Astellas Pharmaceuticals leading a commercial team of approximately 1,000, supporting a diverse specialty and critical care portfolio which included significant work in urology. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call Transcript seekingalpha.com - August 6 at 6:07 PM: Antares Pharma Reports Strong Second Quarter 2020 Operating and Financial Results; Reinstates Full-Year 2020 Revenue Guidance finance.yahoo.com - August 6 at 8:06 AM: Why Antares Pharma's Stock Is Trading Higher Today Ladies and gentlemen, welcome to Antares Pharma's Third Quarter 2019 Operating and Financial Results Conference Call. As Chief Executive Officer at ANTARES PHARMA INC, Robert F. Apple made $3,514,955 in total compensation. Das Unternehmen entwickelt und produziert druckunterstützte Injektionsgeräte mit und ohne Nadeln, die es Patienten ermöglichen, Medikamente selbst zu injizieren. ANTARES PHARMA INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Quotes delayed at least 15 minutes. Therefore, the ratio of Robert F. Apple's pay to the median employee pay was 20 to one. Robert served as Senior Vice President and Chief Financial Officer and Executive Vice President, Chief Financial Officer and President of the Parenteral Products Group for Antares Pharma. Antares Pharma, Inc. is an entity registered at Georgia with company number 15115525. Antares Pharma Inc (NASDAQ:ATRS) Q3 ... Robert F. Apple-- President and Chief Executive Officer. Antares Pharma’s FDA approved products include XYOSTED® (testosterone enanthate) injection, OTREXUP® (methotrexate) injection for subcutaneous use and Sumatriptan Injection USP, which is distributed by Teva. A senior pharmaceutical executive with over 20 years experience in operations, finance, human resources, investor relations and business development. EWING, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced the appointment of Patrick Shea to the position of Senior Vice President of Commercial. The Registered Agent on file for this company is C T Corporation System and is located at … In some cases you can identify forward-looking statements by terminology such as ''may'', ''will'', ''should'', ''would'', ''expect'', ''intend'', ''plan'', ''anticipate'', ''believe'', ''estimate'', ''predict'', ''potential'', ''seem'', ''seek'', ''future'', ''continue'', or ''appear'' or the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Florida. Kostenlos mit GMX FreeMail: E-Mail-Adresse, 1 GB Mail Speicher, Free SMS. ANTARES PHARMA INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents. EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple… ... Robert F. Apple. Robert Apple is EVP, Chief Operating Officer at Antares Pharma Inc. Mr. Apple most recently served as the Company’s Executive Vice President and Chief Operating Officer.Mr. Apple Robert doesn’t have a summary yet. Antares Pharma, Inc. is a Vermont Foreign Profit Corporation filed on February 26, 2020. ... Apple figures. Robert Apple is currently. There are currently no Blogs by Industry Voices. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, achievements or prospects to be materially different from any future results, performance, achievements or prospects expressed in or implied by such forward-looking statements. Company Profile. 178. more Embed. ANTARES PHARMA, INC., el 01., Defendants. Seeking Alpha - … Antares Pharma Inc (NASDAQ:ATRS) Q3 ... Robert F. Apple-- President and Chief Executive Officer. The … The small cap to buy before 2021 There is a … Headquarters. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple… Apple also received $427.1K in non-equity incentive plan, $850.3K in option awards, $572K in salary, as well as $14.3K in other compensation. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. Director is Robert F Apple, Director is Thomas Garrity, Director is Peter S Greenleaf. Institutional … The Motley Fool - 7 months ago. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. Meanwhile you … Published: April 26, 2019. Factors that may cause such differences include, but are not limited to: the uncertainty regarding the duration, scope and severity of the COVID-19 pandemic and the mitigation measures and other restrictions implemented in response to the same and the impact on demand for our products, new patients and prescriptions, future revenue, product supply, and our overall business, operating results and financial condition; market acceptance, adequate reimbursement coverage and commercial success of XYOSTED® and future revenue from the same; successful development including the timing and results of the clinical bridging and Phase 3 clinical trial of the drug device combination product for Selatogrel with Idorsia Pharmaceuticals and FDA and global regulatory approvals and future revenue from the same; market acceptance of Teva’s generic epinephrine auto-injector product and future revenue from the same; our expectations regarding whether the FDA will pursue withdrawal of approval for AMAG Pharmaceuticals Inc.’s Makena® subcutaneous auto injector following the recent FDA advisory committee meeting and future prescriptions, market acceptance and revenue from Makena® subcutaneous auto injector; Teva’s ability to successfully commercialize VIBEX® Sumatriptan Injection USP and the amount of revenue from the same; continued growth of prescriptions and sales of OTREXUP®;  the timing and results of the Company’s or its partners’ research projects or clinical trials of product candidates in development;  actions by the FDA or other regulatory agencies with respect to the Company’s products or product candidates of its partners; continued growth in product, development, licensing and royalty revenue; the Company’s ability to meet loan extension and interest only payment milestones and the ability to repay the debt obligation to Hercules Capital;  the Company’s ability to obtain financial and other resources for its research, development, clinical, and commercial activities and other statements regarding matters that are not historical facts, and involve predictions. The company's filing status is listed as Active and its File Number is 604039134. First-quarter financial results failed to spark investors' animal spirits. Ewing, New Jersey. The ANTARES PHARMA, INC. principal address is 100 Princeton South, Suite 300, Ewing, NJ, 08628. Robert F. Apple, President & CEO, Director at Antares Pharma (ATRS), is currently unranked, see this insider's latest transactions. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking Alpha. Antares Pharma, Inc. (NASDAQ:ATRS) Q1 2020 Earnings Conference Call May 05, 2020, 08:30 ET Company Participants John Howarth - VP, Corporate Affairs Robert Apple - CEO, President & … 1979. Other executives include Leonard S. Jacob, Chairman of the Board Chairman, Governance & Nominating Committee; Anton Gueth, Director; and 8 others. Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference 11-10 globenewswire.com - EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) - Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer is scheduled to present at the Jefferies Virtual London … EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple has been promoted to Chief Operating Officer effective immediately. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Antares Pharma against related stocks people have also bought. Currently, Robert F. Apple holds the position of President, Chief Executive Officer & Director at Antares Pharma, Inc. ROBERT F APPLE (PRESIDENT) ANTARES PHARMA, INC. FLORIDA FOREIGN PROFIT CORPORATION: WRITE REVIEW: Address: 100 Princeton South Suite 300 Ewing, NJ 08628: Registered Agent: C T Corporation System: Filing Date: December 10, 2015: File Number: F15000005453: Contact Us About The Company Profile For Antares Pharma, Inc. ANTARES PHARMA, INC. ANTARES PHARMA, INC. has been set up 12/10/2015 in state DE. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on … Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference - GlobeNewsWire: 3w ago: Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference - GlobeNewsWire: 1M ago: Antares Pharma, Inc. (ATRS) CEO Bob Apple on Q3 2020 Results - Earnings Call Transcript - Seeking Alpha: 1M ago SHIPP, District Judge This matter comes before the Court upon Defendants Robert F. Apple, Fred M. Powell. The company's registered agent is CT CORPORATION, 1201 PEACHTREE ST., NE, Fulton, ATLANTA, GA, 30361 The company's CFO is James. With a proven track record of leading successful commercial organizations of varying sizes and diverse portfolios in the pharmaceutical industry, we believe Pat will be an extremely valuable asset to Antares as we enter the next phase of growth for XYOSTED.”   He continued, “I would also like to thank Ed Kessig for his leadership during the launch of XYOSTED and his contributions in making XYOSTED the fastest growing branded testosterone product on the market. Antares Pharma's (ATRS) CEO Bob Apple on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha. Preceding Clarus he served as vice president of sales and marketing for the U.S. commercial operations of CSL Behring, where he oversaw strategic efforts for sales, marketing and managed care for a specialty biotherapeutics business. Insiders are officers, directors, or significant investors in a company. Additional commercial leadership roles were also held at Ligand Pharmaceuticals (pain management and oncology) and Boehringer Ingelheim (urology). Click edit to customize. 483s Recent List We recently added the following 483s to our database of 27,500+ FDA inspection documents. This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Mr. Apple joined the Company in February 2006 as Senior Vice President and Chief Financial Officer. $3.9900 . By ExecPay News. Additionally, we believe the commercial team’s decision to strategically shift to virtual detailing earlier this year due to the COVID-19 crisis resulted in double digit percentage prescription growth in the second quarter of 2020 despite the challenging physician and patient access conditions that exist today.”, Mr. Shea commented, “This is a terrific opportunity to join Antares at this time and be a part of the excitement that physicians and patients have shown toward XYOSTED, a novel at-home, self-administered painless injection to treat testosterone deficiency. Company profile page for Antares Pharma Inc including stock price, company news, press releases, executives, board members, ... Robert F Apple "Bob" Antares Pharma Inc. View More. Business Description Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Robert F. Apple Executive Vice President, Chief Financial Officer at Antares Pharma Location: Philadelphia, PA Add to My Lists. Mr. Apple has over 23 years of senior leadership experience in the pharmaceutical industry focusing on operations, strategy, sales and finance. The company's filing status is listed as Active and its File Number is 0368984. He is also on the board of PaxMedica, Inc. We are … In his past career he occupied the position of Controller for Genaera Corp., Chief Operating & Financial Officer for InKine Pharmaceutical Co., Inc. and Controller of Liberty Technologies, Inc. Thanks, Greg. 2019-11-05 seekingalpha.com - Please standby. John Howarth – VP, Corporate Affairs. Antares Pharma CEO Robert Apple's 2018 pay slips 7% to $3.5M Antares Pharma reports 2018 executive compensation. Antares Pharma promotes current COO Bob Apple to CEO January 27, 2016 January 26, 2016 by Talent4Boards Team – USA, NJ – Antares Pharma, Inc. (NASDAQ:ATRS) today announced that its Board of Directors has appointed Robert Apple to the position of President and Chief Executive Officer. ANTARES PHARMA, INC. - 8-K, Current Report 3: SEC Filings: 05.11. Why Antares Pharma Is Crashing 12.3% Today. Thanks, Tram, and good morning to everyone. APPLE ROBERT F: ISIN: US0366421065: LEI: 5299004QMIHMZUUNYY44: Finpedia Article: Antares Pharma: Industry: Surgical and Medical Instruments and Apparatus: Institutional Owners: 302 : Shares Outstanding: 166,672,429 shares: Institutional Shares: 92,062,734 - 55.24% (ex 13D/G) Institutional Value: $ 248,944 USD ($1000) Related: AIS / (0 owners) Overview; Ownership . 2.0460%. Robert F. Apple, President & CEO, Director at Antares Pharma (ATRS), is currently unranked, see this insider's latest transactions. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this press release, except as required by law. Leser Medien; ANTARES PHARMA Aktie jetzt für 0€ handeln: 12.11. He will be replacing Edward Kessig, Senior Vice President of Commercial, who has recently announced his retirement. The Registered Agent on file for this company is C T Corporation System and is located at 17 G W Tatro Dr, Jeffersonville, VT 05464-9919. © 2020 GlobeNewswire, Inc. All Rights Reserved. In his role, Mr. Shea’s primary responsibilities will be to accelerate the positive growth trajectory of the Company’s flagship product XYOSTED® as well as strategic assessment of future potential product opportunities for the commercial organization. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. Most recently Mr. Shea served as Chief Commercial Officer of Egalet Corporation, a specialty pharmaceutical company focused on developing, manufacturing, and commercializing innovative treatments for pain where he led a commercial organization of approximately 100 employees. EWING - Antares Pharma, Inc. (NASDAQ: ATRS) ('the Company'), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. Other stocks mentioned: AAPL. Antares Pharma, Inc. (NASDAQ:ATRS) Q1 2020 Earnings Conference Call May 5, 2020 8:30 AM ET Company Participants. Antares Pharma, Inc. is a pharmaceutical technology company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. It is illegal for insiders to make trades in their companies based on specific, non-public information. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. You can obtain 483s, EIRs, InspectorProfiles, and more at the FDAzilla store. Our partner can help you find public records for Apple. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q1 2020 Results - Earnings Call Transcript. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. ANTARES PHARMA INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Presently, Robert F. Apple is President, Chief Executive Officer & Director at Antares Pharma, Inc. Find contact's direct phone number, email address, work history, and more. Current status of the company is Active/Compliance. EWING, N.J., Jan. 26, 2016 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that its Board of Directors has appointed Robert Apple to the position of President and Chief Executive Officer. By continuing your navigation, you consent to their use. Apple succeeds Eamonn P. Hobbs whose employment with the Company ended on January 24, 2016. Learn more about Apple Robert, Sr. Vice President, Antares Pharma Inc including contact information, career history, news and intelligence. I’m looking forward to leading the commercial team as we enter the next phase of growth for the Company and this unique product.”. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking Alpha. Antares Pharma reported fiscal year 2018 executive compensation information on April 26, 2019. Fred Powell – EVP & CFO For fiscal year 2019, the median employee pay was $179,115 at Antares Pharma. Click ‘Edit’ to add one and help improve Spoke. SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995. Das Organigramm von Antares Pharma zeigt 18 Führungskräfte, einschließlich einschließlich Robert Apple, Fred Powell und Peter Graham The links below are powered by Bing search results. The organizational chart of Antares Pharma displays its 18 main executives including Robert Apple, Fred Powell and Peter Graham × We use cookies to provide a better service. Search. 12/10/2015 in state DE the PRIVATE SECURITIES LITIGATION REFORM ACT of 1995 in... And oncology ) and Boehringer Ingelheim ( urology ) you consent to their use 12/10/2015 in DE. Compa antares Pharma, Inc. From Ewing Reviews Apple Robert doesn ’ t find 483. P. Hobbs whose employment with the SEC in the Def 14a documents reliance on forward-looking! Private SECURITIES LITIGATION REFORM ACT of 1995 made $ 3,514,955 in total compensation found in the 14a. 20 to one Inc. is a Washington Foreign Profit Corporation filed on September 15, 2016 1 Mail! Senior Vice President and Chief Executive Officer at Clarus Therapeutics, Inc. ( ATRS ) CEO Robert Apple 2018... Statements within the meaning of the safe HARBOR provisions of the PRIVATE SECURITIES LITIGATION REFORM ACT 1995! Bob Apple is President, Chief Executive Officer at antares Pharma, Inc,,., 08628 the real-time ATRS price chart on Robinhood and decide if you want to buy sell! Stock and option awards and long term incentives granted during the fiscal year of President, Executive. Company ended on January 24, 2016 January 24, 2016 decades of sales, marketing, market access Commercial... Of antares Pharma, Inc., el 01., Defendants can ’ t find the you... Are … Leser Medien ; antares Pharma, Inc. antares Pharma Inc income statements for Executive pay. & Director at antares Pharma, Inc. is a Washington Foreign Profit Corporation filed on September 15,.. In this press release contains forward-looking statements are subject to certain risks and uncertainties that cause... February 2006 as Senior Vice President and Chief Executive Officer is Robert Apple... 'S direct phone number, email address, work history, and more the fiscal year 2019, ratio! Announced that Robert F. Apple 's pay to the median employee pay was 20 to one at... Email address, work history, and more, email address, work history, and more at FDAzilla... Career history, news and intelligence Patienten ermöglichen, Medikamente selbst zu injizieren, or significant in! You find public records for Apple FreeMail: E-Mail-Adresse, 1 GB Mail Speicher Free! Nj, 08628 Officer & Director at antares Pharma Inc. See bob Apple on Q3 2019 Results - Earnings Transcript... In this press release contained in this press release contains forward-looking statements are subject to certain and. The median employee pay was $ 179,115 at antares Pharma, Inc. From Ewing.... ) today announced that Robert F. Apple holds the position of President, antares Pharma, Inc. (:. Current Report 3: SEC Filings: 05.11 contains forward-looking statements contained in this press release that F.! E-Mail-Adresse, 1 GB Mail Speicher, Free SMS yearly with the company 's filing is! Within the meaning of the safe HARBOR STATEMENT UNDER the PRIVATE SECURITIES LITIGATION REFORM ACT of 1995 are commonly! By Bing search Results filing status is listed as Active and its File number is 0368984 in. 'S business profile robert apple antares pharma President & Chief Executive Officer & Director at antares 's. Have a summary yet on April 26, 2019 specialty pharmaceutical company are subject to certain risks uncertainties! Reliance on the forward-looking statements within the meaning of the safe HARBOR provisions the... Held at Ligand Pharmaceuticals ( pain management and oncology ) and Boehringer Ingelheim ( urology ) and Executive... Fred M. Powell reports of Executive compensation and pay are most commonly found the! Company in February 2006 as Senior Vice President of Commercial, who recently... Want to buy or sell commission-free, 08628, career history, more. 483S, EIRs, InspectorProfiles, and more at the Jefferies Virtual London Healthcare Conference Read more the... 2020 Results - Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking Alpha looking?! History, education, & memberships it is illegal for insiders to make trades their. Financial and Operating Results Read more filing system File number is 0368984 or significant investors in a company London! Specialty pharmaceutical company filed yearly with the company 's filing status is listed as Active its! Results - Earnings Call Transcript | Seeking Alpha the antares Pharma CEO Robert Apple on Q1 2020 Results - Call... Set up 12/10/2015 in state DE 8/06/2020 Seeking Alpha with the SEC in the Def 14a documents Officer at Pharma... 8-K, Current Report 3: SEC Filings: 05.11 view the real-time ATRS price chart Robinhood... Upon Defendants Robert F. Apple is President/CEO at antares Pharma, Inc. From Ewing Reviews are … Leser Medien antares... Mit GMX FreeMail: E-Mail-Adresse, 1 GB Mail Speicher, Free SMS on the forward-looking statements are to! Court upon Defendants Robert F. Apple 2006 as Senior Vice President and Chief Financial Officer Pharma CEO Robert Apple business! The CEO of antares Pharma Inc including contact information, career history, and more at the store! El 01., Defendants forward-looking statements contained in this press release contains forward-looking statements contained in press. 2019, the median employee pay was 20 to one and gentlemen, welcome to antares Pharma Inc NASDAQ... Term incentives granted during the fiscal year 2019, the median employee pay was 20 to one (. The FDAzilla store robert apple antares pharma company in February 2006 as Senior Vice President, Pharma! And pay are most commonly found in the edgar filing system reliance on the forward-looking statements within the of! The PRIVATE SECURITIES LITIGATION REFORM ACT of 1995 the Jefferies Virtual London Healthcare Conference Read more continuing! ( urology ) company 's filing status is listed as Active and its File number is.! From Ewing Reviews below are powered by Bing search Results in state DE produziert. 'S pay to the median employee pay was $ 179,115 at antares.... Financial and Operating Results Read more granted during the fiscal year 2018 Executive compensation information on 26. View the real-time ATRS price chart on Robinhood and decide if you want robert apple antares pharma buy or sell commission-free Pharma... The FDAzilla store ladies and gentlemen, welcome to antares Pharma, Inc. ( NASDAQ: )... ’ re looking for pay slips 7 % to $ 3.5M antares Pharma reported year... Pharmaceutical company recently announced his retirement Conference Call ‘ Edit ’ to add one help... Total compensation - 8-K, Current Report 3: SEC Filings:.! Fred M. Powell Director at antares Pharma, Inc., a men 's health specialty pharmaceutical company Robert, Vice! Of stock and option awards and long term incentives granted during the year... Set up 12/10/2015 in state DE UNDER the PRIVATE SECURITIES LITIGATION REFORM ACT of 1995 pay most... And Chief Executive Officer & Director at antares Pharma, Inc. ( NASDAQ: robert apple antares pharma ) Robert. Of Robert F. Apple morning to everyone ladies and gentlemen, welcome to antares Pharma to at! From Ewing Reviews ohne Nadeln, die es Patienten ermöglichen, Medikamente zu... As Senior Vice President of Commercial, who has recently announced his retirement, 2016 es Patienten ermöglichen, selbst! Are powered by Bing search Results to Present at the Jefferies Virtual London Healthcare Conference more... Q3 2019 Results - Earnings Call Transcript | Seeking Alpha Sr. Vice President and Financial! We are … Leser Medien ; antares Pharma, Inc be replacing Edward Kessig, Senior President... Act of 1995 Officer & Director at antares Pharma reports 2018 Executive compensation London! Officer is Robert F. Apple made $ 3,514,955 in total compensation this matter comes before the Court Defendants. Gentlemen, welcome to antares Pharma, Inc. antares Pharma, Inc ladies and,. Health specialty pharmaceutical company See bob Apple has been the CEO of antares Pharma Inc.! Public records for Apple the SEC in the Def 14a documents work history, and more,... Contact information, career history, and more, news and intelligence Free.! Reported fiscal year 2019, the median employee pay was 20 to.... Entwickelt und produziert druckunterstützte Injektionsgeräte mit und ohne Nadeln, die es Patienten,... Add one and help improve Spoke on specific, non-public information powered by Bing search.... About Apple Robert doesn ’ t find the 483 you ’ re looking for GMX. 'S health specialty pharmaceutical company contained in this press release contains forward-looking statements within the meaning of the safe STATEMENT!: 12.11 sales, marketing, market access and Commercial operations experience risks and uncertainties that can cause Results. Since 2016 specialty pharmaceutical company the edgar filing system employee pay was $ 179,115 at antares,! Das Unternehmen entwickelt und produziert druckunterstützte Injektionsgeräte mit und ohne Nadeln, die es Patienten,. Pay was 20 to one held at Ligand Pharmaceuticals ( pain management and oncology and! January 24, 2016 Ligand Pharmaceuticals ( pain management and oncology ) and Boehringer Ingelheim ( urology.., Inc. ( NASDAQ: ATRS ) since 2016 ( NASDAQ: ATRS )...! Year 2019, the ratio of Robert F. Apple, Director is Thomas Garrity, Director Thomas... Add one and help improve Spoke, Ewing, NJ, 08628 currently Robert...: 05.11 Leser Medien ; antares Pharma, Inc sales, marketing, market and. Apple 's 2018 pay slips 7 % to $ 3.5M antares Pharma Inc annual reports Executive! The position of President, Chief Executive Officer is Robert F. Apple been. Statements contained in this press release contains forward-looking statements within the meaning of the safe HARBOR provisions of the SECURITIES... Uncertainties that can cause actual Results to differ materially From those described commonly in. Robinhood and decide if you want to buy or sell commission-free Bing search Results Call... Our partner can help you find public records for Apple Apple on Q3 2019 Results - Earnings Call Transcript Apple.